Allurion Technologies Inc
ALUR_t0.025USD
+0.000+0.40%
Close 12/24, 13:00（ET）Quotes delayed by 15 min
0.00Market Cap
--P/E TTM
More Details of Allurion Technologies Inc Company
Allurion Technologies, Inc. offers Allurion Program, which is a weight loss platform that combines the Allurion Gastric Balloon for weight loss. The Company offers Allurion Virtual Care Suite, including the Allurion Mobile App for consumers, Allurion Insights for health care providers featuring the Iris AI Platform and health tracker devices. Its health tracker devices include Allurion Connected Scale and Allurion Health Tracker. Allurion Connected Scale offers a complete weight tracking experience, allowing users to monitor their weight, body mass index (BMI) and body composition. Allurion Health Tracker tracks steps, exercise and sleep. Allurion Virtual Care Suite is available to providers separately from the Allurion Program to help customize, monitor and manage weight-loss therapy for patients regardless of their treatment plan, which includes gastric balloon, surgical and medical or nutritional. Its Allurion Programme is offered in six months, 12 months and 12-18 months program.
Allurion Technologies Inc Info
Ticker SymbolALUR_t
Company nameAllurion Technologies Inc
IPO dateMar 29, 2021
CEODr. Shantanu Gaur, M.D.
Number of employees- -
Security type- -
Fiscal year-end- -
Address11 Huron Dr Ste 200
CityNATICK
Stock exchange- -
CountryUnited States of America
Postal code01760
Phone15086474000
Websitehttps://www.allurion.com/en
Ticker SymbolALUR_t
IPO dateMar 29, 2021
CEODr. Shantanu Gaur, M.D.
Company Executives of Allurion Technologies Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Krishna K. Gupta
Mr. Krishna K. Gupta
Independent Director
Independent Director
--
--
Mr. Nicholas Sheridan (Nick) Lewin
Mr. Nicholas Sheridan (Nick) Lewin
Independent Director
Independent Director
--
--
Dr. Shantanu Gaur, M.D.
Dr. Shantanu Gaur, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Omar Syed Ishrak, Ph.D.
Dr. Omar Syed Ishrak, Ph.D.
Lead Independent Chairman of the Board
Lead Independent Chairman of the Board
--
--
Mr. Michael Davin
Mr. Michael Davin
Independent Director
Independent Director
--
--
Dr. Ram Chuttani
Dr. Ram Chuttani
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Ojas A. Buch
Mr. Ojas A. Buch
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Larson Douglas Hudson
Mr. Larson Douglas Hudson
Independent Director
Independent Director
--
--
Mr. Brendan M. Gibbons
Mr. Brendan M. Gibbons
Chief Legal Officer, Secretary
Chief Legal Officer, Secretary
--
--
Mr. Mike Cavanaugh
Mr. Mike Cavanaugh
Investor Relations
Investor Relations
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Krishna K. Gupta
Mr. Krishna K. Gupta
Independent Director
Independent Director
--
--
Mr. Nicholas Sheridan (Nick) Lewin
Mr. Nicholas Sheridan (Nick) Lewin
Independent Director
Independent Director
--
--
Dr. Shantanu Gaur, M.D.
Dr. Shantanu Gaur, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Omar Syed Ishrak, Ph.D.
Dr. Omar Syed Ishrak, Ph.D.
Lead Independent Chairman of the Board
Lead Independent Chairman of the Board
--
--
Mr. Michael Davin
Mr. Michael Davin
Independent Director
Independent Director
--
--
Dr. Ram Chuttani
Dr. Ram Chuttani
Chief Medical Officer
Chief Medical Officer
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Mon, Nov 17
Updated: Mon, Nov 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholder Types
Shareholders
Proportion
Other
100.00%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
65
7.01M
0.00%
--
2025Q3
69
7.01M
0.00%
+393.96K
2025Q2
78
6.62M
0.00%
+1.54M
2025Q1
76
5.07M
0.00%
-4.96M
2024Q4
87
5.22M
0.00%
-2.16M
2024Q3
97
7.38M
0.00%
-665.28K
2024Q2
100
8.05M
0.00%
+202.01K
2024Q1
99
7.84M
0.00%
-5.48M
2023Q4
99
7.74M
0.00%
-106.60K
2023Q3
99
7.84M
0.00%
-3.93M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Aristeia Capital, L.L.C.
1.20M
0%
--
--
Jun 30, 2025
Public Investment Fund
1.15M
0%
--
--
Jun 30, 2025
Sage Rock Capital Management LP
1.09M
0%
-17.56K
-1.59%
Sep 30, 2024
LMR Partners LLP
319.50K
0%
--
--
Jun 30, 2025
Clear Street LLC
234.85K
0%
-100.00
-0.04%
Jun 30, 2025
Wolverine Asset Management, LLC
212.96K
0%
-5.80K
-2.65%
Jun 30, 2025
Saba Capital Management, L.P.
122.68K
0%
--
--
Jun 30, 2025
Davidson Kempner Capital Management LP
97.83K
0%
--
--
Jun 30, 2025
Susquehanna International Group, LLP
49.14K
0%
+49.14K
--
Jun 30, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Allurion Technologies Inc?
The top five shareholders of Allurion Technologies Inc are:
Aristeia Capital, L.L.C. holds 1.20M shares, accounting for 0.00% of the total shares.
Public Investment Fund holds 1.15M shares, accounting for 0.00% of the total shares.
Sage Rock Capital Management LP holds 1.09M shares, accounting for 0.00% of the total shares.
LMR Partners LLP holds 319.50K shares, accounting for 0.00% of the total shares.
Clear Street LLC holds 234.85K shares, accounting for 0.00% of the total shares.
Aristeia Capital, L.L.C. holds 1.20M shares, accounting for 0.00% of the total shares.
Public Investment Fund holds 1.15M shares, accounting for 0.00% of the total shares.
Sage Rock Capital Management LP holds 1.09M shares, accounting for 0.00% of the total shares.
LMR Partners LLP holds 319.50K shares, accounting for 0.00% of the total shares.
Clear Street LLC holds 234.85K shares, accounting for 0.00% of the total shares.
What are the top three shareholder types of Allurion Technologies Inc?
The top three shareholder types of Allurion Technologies Inc are:
Other
Other
How many institutions hold shares of Allurion Technologies Inc (ALUR_t)?
As of 2025Q4, 65 institutions hold shares of Allurion Technologies Inc, with a combined market value of approximately 7.01M, accounting for --% of the total shares. Compared to 2025Q3, institutional shareholding has increased by --.
What is the biggest source of revenue for Allurion Technologies Inc?
In --, the -- business generated the highest revenue for Allurion Technologies Inc, amounting to -- and accounting for --% of total revenue.
